Mark Bolstridge
Impact in
- Clinical Psychology top 0.2%
- Psychedelics and Drug Studies
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
Papers in
-
- Psychedelics and Drug Studies 14
-
- Memory and Neural Mechanisms 2
- Co-authors
- Robin Carhart‐Harris (12 shared papers)Mendel Kaelen (11 shared papers)Amanda Feilding (11 shared papers)David Nutt (4 shared papers)David Erritzøe (4 shared papers)Michael Bloomfield (4 shared papers)David Nutt (8 shared papers)David Taylor (2 shared papers)
- Journals
- Psychopharmacology (3 papers)The British Journal of Psychiatry (1 paper)European Neuropsychopharmacology (1 paper)Journal of Clinical Psychopharmacology (1 paper)Journal of Neuroscience (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Bolstridge
16 papers receiving 3.6k citations
Mark Bolstridge's Hit Papers
Peers
Comparison fields: 5 of 83
- Clinical Psychology 3.3k
- Biological Psychiatry 260
- Cellular and Molecular Neuroscience 1.4k
- Organic Chemistry 1.4k
- Toxicology 100
Countries citing papers authored by Mark Bolstridge
This map shows the geographic impact of Mark Bolstridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bolstridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bolstridge more than expected).
Fields of papers citing papers by Mark Bolstridge
This network shows the impact of papers produced by Mark Bolstridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bolstridge. The network helps show where Mark Bolstridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bolstridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study Hit paper breakdown → | 2016 | 1088 |
| 2 | Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Hit paper breakdown → | 2017 | 681 |
| 3 | Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms Hit paper breakdown → | 2017 | 413 |
| 4 | Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution Hit paper breakdown → | 2016 | 347 |
| 5 | 2013 | 347 | |
| 6 | 2016 | 241 | |
| 7 | 2014 | 228 | |
| 8 | 2015 | 114 | |
| 9 | 2016 | 94 | |
| 10 | 2013 | 81 | |
| 11 | 2016 | 35 | |
| 12 | 2016 | 34 | |
| 13 | 2017 | 30 | |
| 14 | 2020 | 23 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 5 | |
| 17 | 2013 | 1 |
About Mark Bolstridge
Mark Bolstridge is a scholar working on Clinical Psychology, Cognitive Neuroscience, Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Nutrition and Dietetics, having authored 17 papers that have together received 3.8k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (14 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Memory and Neural Mechanisms (2 papers), Mental Health Research Topics (2 papers), Schizophrenia research and treatment (2 papers), Biochemical Analysis and Sensing Techniques (2 papers), Tryptophan and brain disorders (1 paper) and Social Representations and Identity (1 paper). The work is most often cited by research in Clinical Psychology (3.3k citations), Biological Psychiatry (260 citations), Cellular and Molecular Neuroscience (1.4k citations), Organic Chemistry (1.4k citations) and Toxicology (100 citations). Mark Bolstridge has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robin Carhart‐Harris, Mendel Kaelen, Amanda Feilding, David Nutt, David Erritzøe, Michael Bloomfield, David Nutt, David Taylor, James Rucker and James A. Rickard. Their work appears in journals such as Psychopharmacology, The British Journal of Psychiatry, European Neuropsychopharmacology, Journal of Clinical Psychopharmacology and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.